title: Can serum soluble CD23 or CD30 predict the occurrence of lymphoma in HIV-infected patients?
authors.forename: Irène
authors.initials: I
authors.lastname: Jarrin
authors.forename: Bernadette
authors.initials: B
authors.lastname: Boval
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Mazeron
authors.forename: Guy
authors.initials: G
authors.lastname: Simoneau
authors.forename: Jean-Dominique
authors.initials: JD
authors.lastname: Magnier
authors.forename: Andrew
authors.initials: A
authors.lastname: Green
authors.forename: Annalisa
authors.initials: A
authors.lastname: Andreoli
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Bergmann
authors.forename: Pierre
authors.initials: P
authors.lastname: Sellier
mesh_terms: D000328:Adult; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000378:metabolism; D006801:Humans; D017730:Ki-1 Antigen / Q000097:blood* / Q000235:genetics / Q000378:metabolism; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D017455:Receptors, IgE / Q000097:blood* / Q000235:genetics / Q000378:metabolism
chemical_list: D017730:Ki-1 Antigen; D017455:Receptors, IgE